🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thrilled to get this published. The FIND trial demonstrates the ability to reduce radiotherapy volumes after TORS for unknown primary. This includes the ability to spare the pharynx with subjective and objective improvements in swallowing: pubmed.ncbi.nlm.nih.gov/38602692/

Incredibly Proud of our superstar residents Hugh Kim and Tanya Chen U of T Otolaryngology - Head & Neck Surgery with their Poliquin Resident Research Awards 2024! CSOHNS ALWAYS a blast catching up with friends and colleagues at CSOHNS John De Almeida Jonathan Yip Joel Davies Christopher MKL Yao, MD. FRCSC Philip Edgcumbe, MD, PhD

How virtual surgical planning allows us to deliver sophisticated reconstructions ⬇️ About Dr. John De Almeida and his work: uhnotohns.ca/team/dr-john-d… ralph gilbert Christopher MKL Yao, MD. FRCSC U of T Otolaryngology - Head & Neck Surgery Princess Margaret Cancer Centre Princess Margaret Cancer Centre Research

BAD NEWS! -- Xevinapant +cis in HN Phase 3 negative at interim -- cis ineligible study closing down -- not great news for #hncsm #radonc NRG Oncology (h/t Yao Yu) C. Jillian Tsai, MD, PhD Sana Karam, MD, PhD Nancy Lee Henning Willers, MD, FASTRO emdgroup.com/en/news/xevina…

Join prominent experts from Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center, & University of Toronto for the 2024 #MSKHeadNeckCME. Explore the latest in epidemiology, multidisciplinary approaches, & advanced surgical techniques through a series of lectures, discussions, & debates: bit.ly/HeadNeck2024

What an amazing way to start Friday! Go #TeamUHN!

‼️Sue Yom presenting NRG Oncology HN005 interim analysis ASTRO #ASTRO24. Safe to say concurrent IO-RT (as of current field/delivery) is not beneficial across disease sites. But given all negative HN trials even for other drug studies thus far, where do we go from here? Nancy Lee

🚨👀ASTRO #ASTRO24 #LBA Radiation Medicine Program Radiation Oncology Princess Margaret Cancer Centre's very own Scott Bratman presenting CCTG Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) for HPV+ OPC. 🌟 2-yr LRC: 94.8% 🌟 2-yr out-of-field LC: 99% (one failed with ipsilateral RT)

Can Lymphatic mapping guide neck management in second primary or recurrent oral cavity cancers with prior neck treatment? Our latest study found up to 38% with anomalous drainage. sciencedirect.com/science/articl… Michael De Biasio John De Almeida Ali Hosni C. Jillian Tsai, MD, PhD UHN Otolaryngology Head & Neck Surgery

An unforgettable evening celebrating John De Almeida and Dr. Kevin M. Higgins becoming Full Professors! 🎉 Surrounded by family, friends, and colleagues, the pride and joy in the room were undeniable. We’re so proud of their achievements!

🔥Hot off the press Our study examines the impact of surgeon-radiation oncologist dyads on the treatment of oral cavity squamous cell cancer, focusing on surgery-postoperative-radiation interval and disease specific outcomes. Read more: tinyurl.com/2k2zrf7b

Interested in leading Medical Oncology and Hematology at one of the best cancer centres in the world? Apply to be the next Division Head of Medical Oncology and Hematology Princess Margaret Cancer Centre University Health Network sinai University of Toronto jobs.utoronto.ca/job/Toronto-As…

We are leading a trial that looks to preserve patients with oropharyngeal cancer from over-treatment with radiation, providing a more personalized approach and better outcomes. ➡️SELECT Trial John De Almeida

Today marks 3 years since the passing of Fred Gentili, a true giant in neurosurgery and my mentor. Fred’s dedication, brilliance, and humility shaped the field of skull base and pituitary surgery. Grateful to carry forward his lessons every day. #Neurosurgery #SkullBaseSurgery

International Academy of Oral Oncology This is going to be a fantastic meeting with many distinguished speakers and updates of cutting edge techniques and clinical trials Deepa Nair John De Almeida Claire Paterson 💙 Soudeh Chegini AHNS

Among patients with oral cavity squamous cell carcinoma, preoperative clinical and tumor characteristics can adequately identify patients who are more likely to receive adjuvant therapy. ja.ma/4c4Txxk CSO HNS Collaborative Research Initiative Gabriel Dayan Antoine Eskander MD ScM John De Almeida

Great educational tool for patients to better understand head and neck surgery and free flap reconstruction. Thanks for the collaboration and amazing video production TVASurg. pie.med.utoronto.ca/TVASurg/projec…. UHN Sprott Department of Surgery UHN Otolaryngology Head & Neck Surgery

Christopher MKL Yao, MD. FRCSC John De Almeida showed that 💠Post-tx PRO can predict HNC Recurrence. 💠ML models using MDASI > general PRO for recurrences. Development of a patient reported outcomes based machine learning mode... sciencedirect.com/science/articl… UHN Otolaryngology Head & Neck Surgery Princess Margaret Cancer Centre Ali Hosni

Another great UHN Otolaryngology Head & Neck Surgery Princess Margaret Cancer Centre Wharton Day in the books and thanks for the opportunity to participate again. Great experience Predicting the Future of Head and Neck Oncology #hncsm along with Nancy Lee, John De Almeida, Neil Hayes, Bill Lydiatt, and Ralph Gilbert

After months of planning, only a few days left before the 9th international symposium for sentinel node biopsy opens at IAOO 2025. So looking forward to hearing this brilliant program of speakers See you in Liverpool eu.eventscloud.com/website/14087/…